CBN
Selected indexed studies
- A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. (Exp Clin Psychopharmacol, 2024) [PMID:37796540]
- Cannabinol (CBN) alleviates age-related cognitive decline by improving synaptic and mitochondrial health. (Redox Biol, 2025) [PMID:40412024]
- Biography: Karen Flanders, MSN, ARNP, CBN. (Obes Surg, 2020) [PMID:32929679]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. (2024) pubmed
- Cannabinol (CBN) alleviates age-related cognitive decline by improving synaptic and mitochondrial health. (2025) pubmed
- Biography: Karen Flanders, MSN, ARNP, CBN. (2020) pubmed
- Electrophilic fluorination of cannabinol (CBN). (2025) pubmed
- Celebrating 30 Years of CBN. (2018) pubmed
- Skin-Whitening Effects of Cannabinol (CBN) Through Melanin Inhibition in B16F10 Melanoma Cells. (2025) pubmed
- Columbianadin ameliorates rheumatoid arthritis by attenuating synoviocyte hyperplasia through targeted vimentin to inhibit the VAV2/Rac-1 signaling pathway. (2025) pubmed
- Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. (2023) pubmed
- Cannabinoid receptor 2 (Cb2r) mediates cannabinol (CBN) induced developmental defects in zebrafish. (2022) pubmed
- Heterogeneous Diamond-cBN Composites with Superb Toughness and Hardness. (2022) pubmed